It's super effective funding. There are known DNA changes that would probably help all people with chronic diseases, but it's ethically more accepted to go for

It's super effective funding. There are known DNA changes that would probably help all people with chronic diseases, but it's ethically more accepted to go for the more fatal diseases and cleaner cases first, like a rare mutation with a high fix rate.